Yes, the intention is to take Yervoy+Cavatak to phase 3, almost certainly for pd-1/pd-l1 inhibitor failed (refractory) patients, i.e those who have failed to respond to keytruda, opdivo (or Lepu's similar products).
Yes, the intention is to take Yervoy+Cavatak to phase 3, almost...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
